Skip to content

HLC VGC MANAGEMENT IV LIMITED

HLC VGC MANAGEMENT IV LIMITED is a Series C+ fund in Asia investing in healthcare-tech and technology.

Stages
Series C+
Sectors
healthcare-tech, technology
Invests in
Asia
Assets under management
$3B+

Check size not disclosed

Thesis

HLC VGC MANAGEMENT IV LIMITED operates as an Exempt Reporting Adviser. While specific details for this entity are limited, its affiliated HighLight Capital (HLC) is a private investment firm dedicated to promoting technology innovations and building a world-class health-focused investment platform. HLC leverages deep knowledge in chemical, biological, and material sciences with a pragmatic and diversified investment philosophy driven by specialized fundamental industry research. The broader HighLight Capital entity, including HLC VGC Partners HK II Limited, has over US$3 billion in AUM as of August 2023. The fund appears to focus on growth-stage companies within the healthcare and technology sectors, with a potential geographic scope including Asia. Investments are made through equity transfers and capital injections.

Common questions

Does HLC VGC MANAGEMENT IV LIMITED invest at the Series C+ stage?

Yes. HLC VGC MANAGEMENT IV LIMITED lists Series C+ among the stages it invests in.

Where does HLC VGC MANAGEMENT IV LIMITED invest?

HLC VGC MANAGEMENT IV LIMITED invests in Asia.